Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03177141

Ligand	Ligand name	Chain	PDB	Tanimoto
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.71
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.75
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.73
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.73
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.72
V2H	(1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol	A,B	3DL9	0.71
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.71
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.72
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.71
PID	PERIDININ	A	2C9E	0.79
PID	PERIDININ	M,N,O	1PPR	0.79
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.73
AUR	AUROVERTIN B	A,B,C,D,E,F	1COW	0.75
DGX	DIGOXIN	B,D	1IGJ	0.75
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.73
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.73
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.73
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.72
VD5	(1R,3R,7E,17E)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4R	0.71
NEX		A,B,C,D,E,F,G,H,I,J	1RWT	0.7
NEX		A,B,C	2BHW	0.7
SWI	SWINHOLIDE A	A,B	1YXQ	0.74
DTX	DIGITOXIGENIN	A	1LNM	0.83
DEX	DEXAMETHASONE	A,D	1M2Z	0.71
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.71
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.72
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.7
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.73
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.72
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.73
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.73
FUG	FUMAGILLIN	A,B	3FMQ	0.74
FUG	FUMAGILLIN	A	1BOA	0.74
OBN	OUABAIN	H,L	1IBG	0.78
EB1	SEOCALCITOL	A	1S0Z	0.73
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.74
DOG	DIGOXIGENIN	A	1LKE	0.84
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.73
ERG	ERGOSTEROL	A	1BXM	0.72
ERG	ERGOSTEROL	A	1ZHZ	0.72
ERG	ERGOSTEROL	A,B	2AIB	0.72
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.7
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.7
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.73
MC9	CALCIPOTRIOL	A	1S19	0.7
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.72
VD4	(1R,3R,7E,17Z)-17-(5-hydroxy-1,5-dimethylhexylidene)-2-methylene-9,10-secoestra-5,7-diene-1,3-diol	A	2O4J	0.71
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.73
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.7
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.7
FUA	FUSIDIC ACID	A	1QCA	0.8
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.8
FUA	FUSIDIC ACID	A,B	2VUF	0.8
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.72